Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
10.07
-0.20 (-1.95%)
At close: Oct 19, 2026, 4:00 PM EDT
10.02
-0.05 (-0.50%)
After-hours: Oct 19, 2026, 6:06 PM EDT

Ginkgo Bioworks Holdings Revenue

Ginkgo Bioworks Holdings had revenue of $20.16M in the quarter ending June 30, 2026, a decrease of -48.49%. This brings the company's total for the last twelve months to $111.86M, down -51.54% year-over-year. In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%. That makes Ginkgo Bioworks Holdings the 20,543rd largest company in the world by revenue and 3,121st in the United States.

Revenue (ttm)
$111.86M
Revenue Growth
-51.54%
P/S Ratio
5.21
Revenue / Employee
$273,033
Employees
485
Market Cap
678.12M

Revenue Chart

Revenue by Segment

  • Cell Engineering 132.75M 78.0%
  • Biosecurity Service 37.41M 22.0%

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025170.16M-56.89M-25.06%
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--